Previous reports concerning the neuropathological changes that occur during the course of Alzheimer's disease (AD) implied that relative amounts of cholesterol may influence the structure of brain cortical membranes (Mason et al., 1992) and that phospholipid alterations correlate very well with the formation of senile plaques in AD (Kaufer et al., 1993) . Impaired cholinergic functions in AD have been attributed to impaired choline and phospholipid homeostasis (Wurtman, 1992) . Recently, links have been made between the pathology of AD and apolipoprotein (apo) E. ApoE, a lipid-binding glycoprotein, plays a key role in the transport and metabolism of triglyceride-rich lipoprotein particles and in cholesterol homeostasis (for a review, see Poirier, 1994) . Lipoproteins containing apoE interact with the low-density lipoprotein (LDL) receptor [apoEIB receptor (Goldstein et a!., 1983) ], the LDL receptor-related protein [LRP (Beisiegel et al., 1989; Kowal et al., 1989) ], the very lowdensity lipoprotein (VLDL) receptor (Takahashi et al., 1992) , and perhaps others (Pedreno et al., 1992) to modulate the catabolism of triglyceride-rich lipoprotein particles. The LDL receptor pathway consists of cell surface binding of apoE-or apoB-containing lipoproteins followed by internalization and degradation via a lysosomal pathway. As the incoming cholesterol concentration increases, intracellular cholesterol synthesis is depressed, synthesis of LDL receptors is decreased, and cholesterol esterification and storage are increased (Goldstein et al., 1983) .
In nervous tissue, apoE is involved in the transport of cholesterol in repair, growth, and maintenance of membranes during development or after injury (Boyles et a!., 1989; Poirier et al., 1991 Poirier et al., , 1993a . In response It) PNS injury, macrophages synthesize and release apoE to scavenge the lipids released from degenerating membranes and myelin. In the CNS apoE, released Irorn astrocytes in response to injury, plays a pivotal role in the redistribution of cholesterol and phospholipids during membrane remodeling associated with synaptic plasticity and compensatory synaptogenesis (Poirier et al., 1991, l993a) . The importance of apoE in the brain is further underscored by the absence of other plasma apos such as apoAl and apoB (Roheim ci al., 1979) . Recently, apoE knockout mice were shown to fail to induce compensatory synaptogenesis Ii response to hippocampal deafferentation (Masliah ci al., 1995) and to exhibit marked cognitive impairment in the Morris swim maze test (Poirier et al., 1996) . Owing to the critical role played by apoE and the LDL receptor in compensatory reactive synaptogenesis, we hypothesised that the poor reinnervation capacity observed in most AD patients could be caused by a selective impairment of the apoE/LDL receptor axis (Poirier, 1994) .
Three major isoforms of apoE (E2, E3, and E4) differ by a single unit of net charge (Davignon et al., 1988) . The apoE4 allele frequency is markedly increased in sporadic (Poirier et al., 1993b; and late-onset familial (Corder et al., 1993; Payami et al .,1993) AD. In vitro, amyloid~peptide was shown to bind to apoE; whether apoE4 binds more avidly to apoE3 or the reverse (Ladu et al., 1994) is still an open question. Increased~-amyloid peptide deposition has been reported in the brain (Rebeck et al., 1993; Beffert and Poirier, 1996) of late-onset sporadic AD patients carrying the apoE4 allele. Furthermore, a reduction in choline acetyltransferase activity (a classical hallmark of AD) in AD patients has been shown to correlate with increased apoE4 allele copy number (Poirier, 1994; Soininen et al., 1995) . We showed recently that apoE levels in the hippocampus and cortical areas of AD subjects are reduced according to the apoE4 allele dose, i.e., as apoE4 allele copy number increases, apoE levels decrease (Bertrand ci al., 1995) . These results parallel the low levels of apoE reported in the CSF of nongenotyped AD subects when compared with age-matched controls (Blennow et a!., 1994).
Despite numerous studies delineating the LDL pathway in cultured fibroblasts and hepatocytes, informalion on lipoprotein metabolism in the CNS is scarce. 'Ihe presence of LDL receptors has been reported in the brains of rats (Poirier et al., 1993a) , monkeys (Pitas et al., 1987h) , and rabbits (Swanson et al., 1988 ). LDL receptors have been shown to be present and functional on the human malignant glioma cell lines U-251MG and KMG-5 (Murakami et al., 1990; Rudling et al., 1983) , primary cultures of rat brain astrocytes (Pitas et al., 1987a) and neurons (Poirier et al., 1992) , and rat glial cells (Jung-Testas et al., 1992) . Recently, in normal human brain, LRP immunoreactivity was demonstrated by both neurons (strong) and astrocytes (light), whereas the neuropil of astrocytes demonstrated LDL receptor immunoreactivity (Rebeck et al., 1993) .
To gain a better understanding of basic lipoprotein pathways in cultured astrocytes, we examined binding, internalization, and degradation properties of human ' 25I-LDL to primary cultures of rat astrocytes. To examine potential isoform-specific differences in apoElipoprotein metabolism, functional liposomes, constructed from purified apoE (E2, E3, and E4), were labeled with 251 and used to study binding and internalization characteristics in both cultured rat astrocytes and neurons.
MATERIALS AND METHODS

Cells
Cell cultures solutions and supplies were purchased from Gibco (Burlington, Ontario, Canada) . Primary cultures of type I astrocytes were derived from the cortex of I -2-dayold Sprague-Dawley rats (Charles River, St. Constant, Quebec, Canada) as described by Intebi et al. (1990) . In brief, brains were removed, whole cortex was dissected out, meninges were removed, and tissue was minced in ice-cold dissection medium [Dulbecco's modified Eagle's medium (DMEM) with 20 mM HEPES and gentamicin (50 ng/ml )]. Tissue was then incubated for 15 mm at 37°Cin dissection medium containing dispase (0.5 mg/mI). DNase I (Sigma. St. Louis, MO, U.S.A.) was then added (final concentration, 0.1 mg/mI), tissue was filtered through nylon mesh (Tekto; size 40 mesh), and the cell suspension was washed three times with astrocyte growth medium [50:50 DMEM:Ham's F-l2 nutrient mix with 10% fetal calf serum, penicillin (100 units/mI), streptomycin (100 j~g/ml), amphotericin B (Fungizone; 2.5~.eg/ml),and gentamicin (50 nglml)]. Cells were plated in poly-D-lysine-coated 75-cm2 tissue culture flasks and maintained at 37°Cin a humidified incubator. The next day each culture was washed twice with Hanks' balanced salt solution. When confluent, cells were vigorously rinsed and shaken with phosphate-buffered saline until >95% type I astrocytes remained (confirmed by glial fibrillary acidic protein immunoreactivity). All cells were used within 3 weeks of primary culture. Primary cultures of hippocampal neurons were isolated from the brains of embryonic LongEvans rats exactly as described before by Alonzo et al. (1994) . Before experiments, all cells were plated in 16-mmdiameter wells, grown to 80% confluence, and maintained for an additional 48 h in serum-free DMEM/F-12 medium.
Preparation of apoE-liposomes
Lipoproteins used for the preparation of apoE-containing liposomes were isolated from the plasma of apoE-homozygnus, pregenotyped patients. ApoE was purified as previously described (Brissette et al., 1986) . In brief, phenylmethylsulfonyl fluoride (10 feM), EDTA (0.3 mM), and sodium azide (3~tM) were added to all sera, and human plasma was ultracentrifuged at 8,500,000 g for 30 mm and then twice at 1,800,000 g for 1 h to isolate and wash the VLDL. An equal volume of isopropanol was added to a 1 .5 mg/mI VLDL solution while agitating vigorously and centrifuging at 10,000 g for 10 mm. Isopropanol was evaporated from the supernatant, and acetone (1.2 times the volume) was added to the remaining solution while agitating and centrifuging at 20,000 g for 20 mm. The apoE pellet was resuspended in 150 mM NaC1, and the acetone extraction was repeated. Solvent-extracted apos were then delipidated by extracting twice with chloroform/methanol (2:1 vol/vol); each extraction was followed by a 20-mm centrifugation at 20,00t) g. Delipidated proteins were dissolved in 10 mM Tris-HCI buffer (pH 7.4) containing 150mM NaCI, 0.3 mM EDTA, and 5.0 M urea. The solutions were centrifuged at 10,000 g for 10 mm to remove undissolved material and then dialyzed against the same buffer containing no urea.
Liposomes were prepared according to the method of Matz and Jonas (1982) with the following conditions per mole of protein: 100 mol of phosphatidylcholine, 100 mol of cholate, and 25 mol of cholesterol. The lipid/cholate/ protein mixtures were incubated for 12 h at 4°C and then dialyzed for 2 days against 10mM Tris-HC1 buffer (pH 7.4) containing 150 mM NaCI and 0.3 mM EDTA. The liposomereconstituted proteins were isolated by a centrifugation of 3,000,000 g for 1 h at a density of 1.125 g/ml, and the isolated fraction was dialyzed against a 150 mM NaC1 solution (pH 7.5) containing 0.3 mM EDTA and 3 mM sodium azide.
Radioiodination of lipoproteins
All lipoproteins were labeled according to the BoltonHunter procedure (innerarity et al., 1979) . Benzene was evaporated with a gentle stream of nitrogen, the lipoprotein, in potassium phosphate buffer (pH 7.5), was added, and the mixture was incubated on ice for 5 h with gentle agitation every 30 mm. The reaction was terminated with 0.2 ml of glycine (I mg/mi in phosphate buffer), and the mixture was incubated an additional 15 mm and then applied to a preequilibrated column (Sephadex G-25 equilibrated with 0. I % gelatin-phosphate buffer). Radiolaheled protein fractions were pooled.
Measurement of binding, internalization, and degradation of ' 251-LDL
Binding assays of '251-labeled lipoproteins were measured as described by Innerarity et a!. (1986) . For 4°Cstudies, cells were first placed on ice in a 4°Ccold room, and medium was replaced with ice-cold DMEM containing 0.2% bovine serum albumin. Fresh DMEM/0.2% bovine serum albumin was then added containing the indicated amount of '251-LDL in the presence or absence of a 500-fold excess of unlabeled LDL (to estimate nonspecific binding), and cells were incubated for 4 h at 4°C.Incubation medium was then relnoved and used to for quantifying degradation products. The cells were washed rapidly three times with ice-cold phosphatebuffered saline containing 0.2% bovine serum albumin and then twice for 10 mm with phosphate-buffered saline. To displace LDL hound to its receptor, each well then received phosphate-buffered saline containing dextran sulfate (10 mg/mi), sodium suramin (25 mM), or a mixture of proteases (50 pg/mI of trypsin, 50 jig/mI of proteinase K, and 5 mM EDTA) and then incubated on ice for I h in a rotary shaker (60 rpm). The solution was then counted for radioactivity to determine '251-LDL released. The cells were then rinsed with phosphate-buffered saline and detached with 0.1 M NaOH to determine the amount of radioactivity still associated with the cells. An aliquot of this solution was used to determine the cellular protein concentration. For experiments at 37°C,the medium was replaced with DMEM containing 0.2% bovine serum albumin containing the indicated amount of '251-LDL in the presence or absence of a 500-fold excess of unlabeled LDL. Cells were incubated for 5 h at 37°C, placed at 4°Cfor 15 mm, and processed exactly the same as for the 4°Cstudies. Specific binding and internalization are represented by total cell-associated radioactivity that is sensitive or resistant, respectively, to release by 25 mM suramin minus values obtained in the presence of excess unlabeled LDL. Results are expressed as nanograms of I2~l LDL per milligram of cellular protein unless otherwise specified. K 0 data are expressed as mean ±SE values. The degradation rate of ' 251-LDL was determined by measuring the amount of specific '251-labeled triehloroacetic acid-soluble material in the medium after the incubation as previously described (Goldstein et al., 1983) .
Data analysis
Binding parameters for the various peptides were calculated from the competition binding analyses by the London Software Receptor Fit Competition (Lundon Software, Chagrin Falls, OH, U.S.A.). Scatchard plots were constructed, and the Kj) and B~,, 5values were computed using weighted nonlinear least-squares regression analysis. All results are reported as mean ± SE values. The statistical significance of differences between binding and internalization mean values was evaluated using t test analysis.
RESULTS
Binding, internalization, and degradation of human '
251-LDL by primary cultures of rat astrocytes
The ability of polysulfonated compounds such as heparin, dextran sulfate. and suramin to displace LDL from its receptor has been well established in many cell types (Goldstein et al., 1976; Innerarity al., 1986; Salter et al., 1986) . We first examined the ability of these compounds to displace '251-LDL that had been bound to primary cultures of rat astrocytes at 4°C. Cultured astrocytes deprived of fetal bovine serum for 48 h were incubated with 25l-LDL for 4 h at 4°C, washed, and incubated with buffer containing dextran sulfate, suramin, or proteases at 4°C as described in Materials and Methods. Figure 1 illustrates the proportion of cell-associated radioactivity released by dextran sulfate, suramin, or a mixture of proteases in these conditions. Excess dextran sulfate (100 mg/mI) released~-~50%of the '25I-LDL associated with primary cultures of rat astrocytes. Suramin displaced slightly more of the radioactivity associated with the cells (57%), whereas protease treatment released 48% of the bound '251-LDL. Increasing the incubation time to 2 h had no detectable effect on the amount of 22I~LDL released with any of the above-mentioned agents (data not shown). For all subsequent experiments, 25 mM suramin was used to release the '251-LDL bound to the cells. LDL receptor activity is known to increase in the absence of exogenous cholesterol in many cell types (Goldstein et al., 1983; Innerarity et al., 1986) . We examined the effect of serum deprivation on '251-LDL biiiding and internalization in rat astrocytes. As shown hy Effect of serum deprivation on rat astrocyte-associated "°'l-LDL. Primary cultures of rat astrocytes were plated as described. After 48 h in culture, cells were rinsed, subjected to serum-free conditions for 0, 1, 2, or 3 days, and then incubated at 37°Cfor 5 h with 125l-LDL (10 pg/mI) in the presence or absence of 500 pg of unlabeled LDL/ml to estimate nonspecific binding. Cells were then cooled to 4°C,rinsed, and incubated for 1 h with 25mM sodium suramin asdescribed in Materials and Methods, Specific binding and internalization are represented by total cell-associated radioactivity that is sensitive or resistant, respectively, to 25 mM suramin minus values obtained in the presence of excess unlabeled LDL. Data are mean ± SE (bars) values of triplicate dishes.
FIG. 3.
Time course of specific 125l-LDL binding to rat astrocytes. Primary cultures of rat astrocytes were plated and deprived ofserum for 48 h as described. Cells were then incubated at 4°Cwith 125l-LDL (10 pg/mI) in the presence or absence of unlabeled LDL (500 pg/mI) (to estimate nonspecific binding). At each indicated time, the assay was terminated, and wells were rinsed and then incubated for 1 h at 4°C with 25 mM suramin. Data are mean ±SE (bars) values of triplicate dishes, after subtracting the values for nonspecific binding for suraminreleasable binding (released), suramin-resistant uptake (resistant), and the sum of these (specific bound).
ration at 2 h for both the suramin-releasable component (representing~-.'65%of the specific 25I-LDL associated with the cells) and the suramin-resistant portion (representing~'-~35%of the specific 251-LDL associ- 
FIG. 5.
Saturation curves representing specific binding, internalization, and degradation of human 125l-LDL by rat astrocytes. Primary cultures of rat astrocytes were plated and serum-deprived for 48 h as described. Cells were then incubated at 37°C for 4 h with the indicated concentration of 125l-LDL in the presence or absence of a 500-fold excess of unlabeled [DL (to estimate nonspecific binding). Specific binding and internalization are represented by total cell-associated radioactivity that is sensitive or resistant, respectively, to 25 mM suramin minus values obtained in the presence of excess unlabeled LDL. Specific degradation products were determined as described in Materials and Methods. Data are mean ± SE (bars) values of triplicate dishes after subtracting nonspecific values.
K~2
of 1.8 ±0.14 nM for the higher-affinity binding component and a B,nax of 0.14 ±0.02 pmol/mg. Specificity of 251-LDL binding to rat astrocytes was determined by competitive binding assays performed at 4°C. As shown by Fig. 4b, >70% of the specific '25I-LDL (an apoB-containing lipoprotein) associated with the cells at 4°Cwas displaced by 500 jig/ml of unlabeled LDL. 1251-LDL binding could also be displaced, to a similar extent, by 500~ig/ml of~-VLDL, an apoE-containing lipoprotein (data not shown).
Specific binding, internalization, and degradation of human '251-LDL to rat astrocytes at 37°Care shown in 
Binding of human '251-apoE-liposomes by primary cultures of rat astrocytes and neurons
The second series of experiments examined potential isoform-specific differences in apoE binding in both primary rat cultures of astrocytes and neurons. Because purified apoE does not bind to its receptor, liposomes were constructed from purified apoE that had been isolated from the serum of pregenotyped apoE-homozygous patients. 
DISCUSSION
Cells requiring cholesterol for membrane synthesis are known to take up lipoproteins via receptor-mediated endocytosis or to initiate the de novo synthesis of cholesterol (Goldstein et a!., 1983) . Because the brain lacks key plasma apos such as apoB and apoAl (Roheim et al., 1979) , apoE is the lipid carrier of choice in the CNS, playing a pivotal role in the hippocampal response to injury (Poirier et al., 1991 (Poirier et al., , 1993a . The coordinated expression of apoE and its receptor appears to regulate the transport of cholesterol and phospholipids during the early and intermediate phases of 
FIG. 7.
Effect of apoE isoform on 125l-apoE-liposome binding in rat astrocytes and neurons. Primary cultures of rat cortical astrocytes and hippocampal neurons were plated and serumdeprived for 48 h as described. Cells were incubated at 37°C for 4 h, with 2 pg/mI of 1251-apoE (E2, E3, or E4) liposomes and 500 pg/mI of unlabeled [DL to estimate nonspecific binding. Specific binding is represented by total cell-associated radioactivity that is sensitive or resistant, respectively, to 25mM suramin minus values obtained in the presence of excess unlabeled LDL. Data are mean ±SE (bars) values of triplicate dishes after subtracting the values for nonspecific binding. *~p< 0.01. NS, not significant. icr, 1994). As neurons undergoing dendritic remodeling and synaptogenesis favor cholesterol internalization through the apoE/LDL receptor pathway, theỹ rogressively inhibit cholesterol synthesis (Poirier et al., 1991 (Poirier et al., , 1993a . The recent discoveries that apoE4 is strongly linked to sporadic and familial late-onset AD and that this particular apoE isoform is associated with low levels of apoE in the brain (Bertrand et a!., 1995) raise the possibility that a dysfunction of the lipid transport system associated with compensatory sprouting and synaptic remodeling could be central to the AD process (Poirier, 1994) .
We demonstrate here that primary cultures of rat astrocytes bind, internalize, and degrade '25l-LDL by a specific, saturable, high-affinity process and that uptake is markedly increased within 48 h after changing to serum-free conditions (low lipoprotein concentralions). This confirms a previous report on the ability of cultured astrocytes to metabolize apoE-containing lipoproteins (Pitas et al., 1987a,b) , and confirms in brain cells the previous observations in fibroblasts of I .DL receptor up-regulation in response to lipoprotein deprivation (Goldstein et al., 1983; Innerarity et al., 986) . This is also consistent with previous reports suggesting that the LDL (apoB/E) receptor is present and functional on astrocytes (Pitas et al., 1987a,b; Jung-Testas et a!., 1992) and is responsible for at least a portion of our observed 1251-LDL binding in astrocytes.
Only half of the 251-LDL associated with the cultured rat astrocytes could be released by excess polysulfonated compounds (Figs. 1, 3 , and 4). Suramin was more efficient at displacing 1251-LDL than dextran sulfate. The suramin-resistant 1251-LDL associated with the cells at 4°C probably reflects a small degree of internalization, occurring at low temperatures (Hara and Howard, 1990) . Alternatively, it may suggest the presence of two distinct binding sites, as has been reported in hepatocytes (Salter et al., 1986) . Polysulfonated compounds, such as suramin, interact with the same apoB amino acid residues involved in LDL binding to the LDL receptor (Mahley et al., 1979) . The inability of suramin to release part of the '251-LDL specifically bound to astrocytes implies that these residues are not involved in binding or that these residues are not accessible to suramin when 1251-LDL is bound. Although the LRP (which binds apoE) has been shown to be present on astrocytes (Rebeck et al., 1993) , it cannot bind apoB (the major apo present in human LDL) and therefore is unlikely to be responsible for any '251-LDL binding observed in our studies. Scatchard analysis of the specific '251-LDL bound at 4°C revealed a K 0 of 1.8 nM for the higher-affinity binding component, which is very similar to the value of 3.5 nM reported by Pitas et al. (1987a) using rat LDL rather than human LDL. Competitive binding assays confirmed the specific nature of LDL binding to rat astrocytes (Fig. 4b) . The observation that an excess of human unlabeled VLDL (containing apoE) was able to displace as much ' 251-LDL binding as an excess of human LDL (containing primarily apoB) further supports the notion that the LDL (apoB/E) receptor is responsible for the specific '251-LDL binding.
Studies performed at 37°Crevealed that binding and internalization of 251-LDL reached saturation at low 251-LDL concentrations (Fig. 5) . Degradation, on the other hand, exhibits a more linear relationship at low concentrations, which is consistent with the proposed notion of receptor-dependent and -independent catabolism of lipoprotein complexes. At 37°C,the affinity of the 251-LDL high-affinity binding site was less than that at 4°C(K 0 values were 1.8 and 4.5 nM at 4 and 37°C, respectively), whereas the~was much greater at 37°C. This is consistent with temperature-dependent differences in KD and~values obtained with fibroblasts (Goldstein et al., 1983) .
To examine the role of different apoE isoforms in CNS lipoprotein metabolism, we constructed liposomes from purified apoE that had been isolated from pregenotyped, apoE-homozygous patients. The apoEliposomes were then labeled with 1251 and incubated at 37°Cwith primary cultures of rat cortical astrocytes or hippocampal neurons as described in Materials and
Methods.
Both apoB-containing LDL and apoE-containing VLDL were found to displace, at 37°C,binding and internalization of ' 251-apoE-liposomes to a similar extent. This was true of all isoforms of '251-apoE tested (E2, E3, and E4) in both astrocytes and neurons.
Our studies revealed isoform-specific differences in '251-apoE-liposome apoE3-liposome binding in neurons was found to be markedly increased when compared with '251-apoE4-liposome binding. This is quite interesting in view of the recent demonstration that~-amyloid, a peptide that accumulates preferentially in the brain of apoE4 carriers with AD, is a powerful regulator of apoE internalization and degradation in astrocyte cells in culture (Beffert et al., 1995) . In evolutionary terms, apoE4 is considered to be the ancestral form of apoE, which is found in both rodents and monkeys (Mahley, 1988) . This could explain why rodent cells better handle human apoE4-liposomes when compared with apoE3-liposomes. Alternatively, this phenomenon could represent an intrinsic characteristic of the apoE4!neuron interaction.
Cultured astrocytes, on the other hand, failed to exhibit this preferential binding for apoE3 liposomes. At least two different explanations can be proposed to explain this phenomenon: First, astrocytes may express a different type of LDL receptor or a different combination of cell surface receptors that recognize the apoE3-liposomes (LDL receptor, LRP, or VLDL receptor). Alternatively, apoE synthesized endogenously in astrocytes (but not in neurons) could affect the binding kinetic of the apoE3 isoform without compromising the apoE2 and E4 binding profiles. These different possibilities are now currently being explored in our laboratory.
These results clearly indicate that there are cell-specific differences in the binding properties of the different human apoE isoforms in different brain cells. ApoE concentrations in the brain of AD decrease according to the following gradient: E2 > E3~E4 (Bertrand et al., 1995) . A similar profile was reported for serum apoE levels in young healthy subjects (Utermann, 1987) . A possible interpretation of these results is that apoE2 catabolism, which depends on binding and internalization by scavenging cells such as astrocytes, is significantly reduced when compared with that of apoE3 and apoE4. Alternatively, the catabolism (degradation) of apoE4 could proceed at a higher rate when compared with apoE3, leading to lower steady-state levels of apoE in apoE4 carriers. This mechanism is consistent with the fate of serum apoE4-lipoproteins, which are catabolized more rapidly than apoE3-containing lipoproteins in vivo in humans (Gregg et al., 1986) .
Recently, it was shown that apoE-liposomes (E3 and E4) can bind selectively to soluble~-amy1oid (1-40) and catalyze the internalization of the ,8 A4 peptide into neurons and astrocytes through the LDL receptor pathway (Beffert and Poirier, 1996) . This process can be completely blocked by the presence of an LDL receptor-specific monoclonal antibody raised against the apoE binding site of the receptor. It is thus conceivable that the internalization of~-amy1oid by astrocytes and neurons may proceed at different rates depending on the concentration and type of apoE isoform present in the CNS. Additional work is now required to determine the relevance of these isoform-specific interactions of apoE with its receptor and~-amyloid peptide in vivo, as the relationship between these two key markers may represent an important clue in the understanding of AD pathophysiology.
